BBVA
AGTC

Banco Bilbao Vizcaya Argentaria’s Applied Genetic Technologies Corporation AGTC Stock Holding History

Banco Bilbao Vizcaya Argentaria’s Portfolio AGTC Stock Details AGTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-40,000
Closed -$221K – 789
2020
Q2 		$221K Buy
+40,000
New +$183K 0.01% 695

Other funds holding AGTC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
IVM
InterWest Venture Management San Francisco, California $20.6M AUM 48.5% 1-Year Est. Return
PCM
Portolan Capital Management Boston, Massachusetts $1.88B AUM 115.74% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Banco Bilbao Vizcaya Argentaria's AGTC Position: Q3 2020 in Review

Banco Bilbao Vizcaya Argentaria sold out of Applied Genetic Technologies Corporation (AGTC) in Q3 2020, closing a stake of 40,000 shares — an estimated $221K sold.

Banco Bilbao Vizcaya Argentaria first reported a position in AGTC in Q2 2020 and held it in 1 quarter. The position peaked at $221K in Q2 2020. 71 funds tracked by Wall St. Rank hold AGTC as of Q3 2020.

  • Banco Bilbao Vizcaya Argentaria reported no remaining Applied Genetic Technologies Corporation position as of Q3 2020 after selling out during the quarter.
  • Banco Bilbao Vizcaya Argentaria sold 40,000 Applied Genetic Technologies Corporation shares in Q3 2020, an estimated $221K.
  • Banco Bilbao Vizcaya Argentaria first reported a position in Applied Genetic Technologies Corporation in Q2 2020 and held it in 1 quarter.
  • Banco Bilbao Vizcaya Argentaria's Applied Genetic Technologies Corporation position peaked at $221K in Q2 2020.
  • 71 funds tracked by Wall St. Rank held Applied Genetic Technologies Corporation as of Q3 2020.

Based on Banco Bilbao Vizcaya Argentaria's 13F filing for Q3 2020, filed 12 Nov 2020.